Tech Company Inital Public Offerings

Ra Pharmaceuticals IPO

Headquartered in Cambridge, Ra Pharmaceuticals is now a public company.

Transaction Overview

Company Name
Announced On
Transaction Type
Proceeds Purpose
We currently intend to use the net proceeds from this offering, together with our existing cash and cash equivalents, as follows: approximately $33.0 million to fund clinical development of RA101495 through the completion of a Phase 2 clinical trial in PNH patients; approximately $11.0 million to fund a Phase 2 clinical trial in rMG patients and a Phase 1b clinical trial in LN patients; approximately $18.9 million to advance our pipeline programs in Factor D, oral C5 inhibition and C1s; and the remainder, if any, for working capital and other general corporate purposes.

Company Information

Company Status
Acquired or Merged
Mailing Address
87 Cambridge Park Dr.
Cambridge, MA 02140
Email Address
Ra Pharmaceuticals is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma's peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability.
Ra Pharmaceuticals LinkedIn Company Profile
Social Media
Ra Pharmaceuticals Company Twitter Account
Company News
Ra Pharmaceuticals News
Ra Pharmaceuticals on Facebook
Ra Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Doug Treco
  Doug Treco LinkedIn Profile  Doug Treco Twitter Account  Doug Treco News  Doug Treco on Facebook
Chief Financial Officer
David Lubner
  David Lubner LinkedIn Profile  David Lubner Twitter Account  David Lubner News  David Lubner on Facebook
Chief Medical Officer
Ramin Farzaneh-Far
  Ramin Farzaneh-Far LinkedIn Profile  Ramin Farzaneh-Far Twitter Account  Ramin Farzaneh-Far News  Ramin Farzaneh-Far on Facebook
Chief Scientific Officer
Simon Read
  Simon Read LinkedIn Profile  Simon Read Twitter Account  Simon Read News  Simon Read on Facebook
VP - R & D
Alonso Ricardo
  Alonso Ricardo LinkedIn Profile  Alonso Ricardo Twitter Account  Alonso Ricardo News  Alonso Ricardo on Facebook



Browse more venture capital transactions:

Prev: 10/26/2016: OpenDataSoft venture capital transaction
Next: 10/26/2016: AvidXchange venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary